BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27345450)

  • 1. [New molecular classification of colorectal cancer, pancreatic cancer and stomach cancer: Towards "à la carte" treatment?].
    Dreyer C; Afchain P; Trouilloud I; André T
    Bull Cancer; 2016; 103(7-8):643-50. PubMed ID: 27345450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The consensus molecular subtypes of colorectal cancer.
    Guinney J; Dienstmann R; Wang X; de Reyniès A; Schlicker A; Soneson C; Marisa L; Roepman P; Nyamundanda G; Angelino P; Bot BM; Morris JS; Simon IM; Gerster S; Fessler E; De Sousa E Melo F; Missiaglia E; Ramay H; Barras D; Homicsko K; Maru D; Manyam GC; Broom B; Boige V; Perez-Villamil B; Laderas T; Salazar R; Gray JW; Hanahan D; Tabernero J; Bernards R; Friend SH; Laurent-Puig P; Medema JP; Sadanandam A; Wessels L; Delorenzi M; Kopetz S; Vermeulen L; Tejpar S
    Nat Med; 2015 Nov; 21(11):1350-6. PubMed ID: 26457759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathological classification of colorectal cancer.
    Müller MF; Ibrahim AE; Arends MJ
    Virchows Arch; 2016 Aug; 469(2):125-34. PubMed ID: 27325016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characterization of patients with sporadic colorectal cancer following the new Consensus Molecular Subtypes (CMS)].
    Wielandt AM; Villarroel C; Hurtado C; Simian D; Zamorano D; Martínez M; Castro M; Vial MT; Kronberg U; López-Kostner F
    Rev Med Chil; 2017 Apr; 145(4):419-430. PubMed ID: 28748988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.
    Soldevilla B; Carretero-Puche C; Gomez-Lopez G; Al-Shahrour F; Riesco MC; Gil-Calderon B; Alvarez-Vallina L; Espinosa-Olarte P; Gomez-Esteves G; Rubio-Cuesta B; Sarmentero J; La Salvia A; Garcia-Carbonero R
    Eur J Cancer; 2019 Dec; 123():118-129. PubMed ID: 31678770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer.
    Barrett MT; Anderson KS; Lenkiewicz E; Andreozzi M; Cunliffe HE; Klassen CL; Dueck AC; McCullough AE; Reddy SK; Ramanathan RK; Northfelt DW; Pockaj BA
    Oncotarget; 2015 Sep; 6(28):26483-93. PubMed ID: 26317899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive molecular characterization of gastric adenocarcinoma.
    Cancer Genome Atlas Research Network
    Nature; 2014 Sep; 513(7517):202-9. PubMed ID: 25079317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil.
    Lei Z; Tan IB; Das K; Deng N; Zouridis H; Pattison S; Chua C; Feng Z; Guan YK; Ooi CH; Ivanova T; Zhang S; Lee M; Wu J; Ngo A; Manesh S; Tan E; Teh BT; So JB; Goh LK; Boussioutas A; Lim TK; Flotow H; Tan P; Rozen SG
    Gastroenterology; 2013 Sep; 145(3):554-65. PubMed ID: 23684942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus molecular subtype classification of colorectal adenomas.
    Komor MA; Bosch LJ; Bounova G; Bolijn AS; Delis-van Diemen PM; Rausch C; Hoogstrate Y; Stubbs AP; de Jong M; Jenster G; van Grieken NC; Carvalho B; Wessels LF; Jimenez CR; Fijneman RJ; Meijer GA;
    J Pathol; 2018 Nov; 246(3):266-276. PubMed ID: 29968252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD-L1 Is Upregulated by Simultaneous Amplification of the PD-L1 and JAK2 Genes in Non-Small Cell Lung Cancer.
    Ikeda S; Okamoto T; Okano S; Umemoto Y; Tagawa T; Morodomi Y; Kohno M; Shimamatsu S; Kitahara H; Suzuki Y; Fujishita T; Maehara Y
    J Thorac Oncol; 2016 Jan; 11(1):62-71. PubMed ID: 26762740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer without high microsatellite instability and chromosomal instability--an alternative genetic pathway to human colorectal cancer.
    Tang R; Changchien CR; Wu MC; Fan CW; Liu KW; Chen JS; Chien HT; Hsieh LL
    Carcinogenesis; 2004 May; 25(5):841-6. PubMed ID: 14729584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic pathways in colorectal cancer: interest for the pathologist].
    Piard F; Martin L; Chapusot C; Ponnelle T; Faivre J
    Ann Pathol; 2002 Sep; 22(4):277-88. PubMed ID: 12410150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptomic Profiling of MSI-H/dMMR Gastrointestinal Tumors to Identify Determinants of Responsiveness to Anti-PD-1 Therapy.
    Chida K; Kawazoe A; Suzuki T; Kawazu M; Ueno T; Takenouchi K; Nakamura Y; Kuboki Y; Kotani D; Kojima T; Bando H; Mishima S; Kuwata T; Sakamoto N; Watanabe J; Mano H; Ikeda M; Shitara K; Endo I; Nakatsura T; Yoshino T
    Clin Cancer Res; 2022 May; 28(10):2110-2117. PubMed ID: 35254400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence of molecular genetic events in colorectal tumorigenesis.
    Laurent-Puig P; Blons H; Cugnenc PH
    Eur J Cancer Prev; 1999 Dec; 8 Suppl 1():S39-47. PubMed ID: 10772417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic mutations of ERBB2 kinase domain in gastric, colorectal, and breast carcinomas.
    Lee JW; Soung YH; Seo SH; Kim SY; Park CH; Wang YP; Park K; Nam SW; Park WS; Kim SH; Lee JY; Yoo NJ; Lee SH
    Clin Cancer Res; 2006 Jan; 12(1):57-61. PubMed ID: 16397024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies.
    Sveen A; Bruun J; Eide PW; Eilertsen IA; Ramirez L; Murumägi A; Arjama M; Danielsen SA; Kryeziu K; Elez E; Tabernero J; Guinney J; Palmer HG; Nesbakken A; Kallioniemi O; Dienstmann R; Lothe RA
    Clin Cancer Res; 2018 Feb; 24(4):794-806. PubMed ID: 29242316
    [No Abstract]   [Full Text] [Related]  

  • 17. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.
    Woodford-Richens KL; Rowan AJ; Gorman P; Halford S; Bicknell DC; Wasan HS; Roylance RR; Bodmer WF; Tomlinson IP
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9719-23. PubMed ID: 11481457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal serrated adenocarcinoma shows a different profile of oncogene mutations, MSI status and DNA repair protein expression compared to conventional and sporadic MSI-H carcinomas.
    García-Solano J; Conesa-Zamora P; Carbonell P; Trujillo-Santos J; Torres-Moreno D D; Pagán-Gómez I; Rodríguez-Braun E; Pérez-Guillermo M
    Int J Cancer; 2012 Oct; 131(8):1790-9. PubMed ID: 22287190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cigarette smoking and K-ras mutations in pancreas, lung and colorectal adenocarcinomas: etiopathogenic similarities, differences and paradoxes.
    Porta M; Crous-Bou M; Wark PA; Vineis P; Real FX; Malats N; Kampman E
    Mutat Res; 2009; 682(2-3):83-93. PubMed ID: 19651236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylinositol-3-kinase pathway aberrations in gastric and colorectal cancer: meta-analysis, co-occurrence and ethnic variation.
    Chong ML; Loh M; Thakkar B; Pang B; Iacopetta B; Soong R
    Int J Cancer; 2014 Mar; 134(5):1232-8. PubMed ID: 23960014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.